Search

everythinglearnresearchcommunity

for

Search:↓

A severe virus outbreak in yaks on the Qinghai-Tibet Plateau caused high death rates and requires targeted control measures.

Understanding T cells and signaling pathways can lead to better treatments for hair loss.

JAK inhibitors show promise for treating various skin diseases.

Understanding how Regulatory T Cells work could help create treatments for certain skin diseases and cancers.

Alopecia areata is an autoimmune disease with genetic links, treatable with certain medications, and can affect mental health.

The combined stem cell secretome in the skin care product effectively reduces inflammation and promotes tissue regeneration.

Combining hyperthermia with natural compounds and conventional treatments improves cancer therapy effectiveness and reduces side effects.

New drug delivery systems show promise in effectively treating pathological scars.

Regulatory T cells and mesenchymal stem cells work together to prevent immune system overreactions and tissue damage.

Targeting pyroptosis may offer new treatments for alopecia areata, but more research is needed.

Early intervention in patch-type alopecia may prevent progression to more severe forms by targeting immune pathways and preserving keratin.

Accurate diagnosis and personalized treatment are crucial in dermatopathology.

Specific immune cells and pathways contribute to hair follicle inflammation and hair loss, suggesting potential treatments for lichen planopilaris.

UTMD with diclofenac and Doxil® improves cancer treatment by boosting immune response and reducing tumor-supporting cells.

Psoriasis involves immune and genetic factors, and understanding these can improve treatments.

Timely and aggressive treatment is crucial for improving outcomes in severe complications of adult-onset Still's disease.

Both cryotherapy and FCO2 laser are effective and safe for treating patchy alopecia areata.

Cellular and immunotherapies show promise for healing chronic wounds but need more research.

Alopecia areata and vitiligo share immune system dysfunction but differ in specific immune responses and affected areas.

Hair proteins in preschool children and their mothers could indicate developmental changes and health status.

Human skin xenografting could improve our understanding of skin development, renewal, and healing.

Treg cell-based therapies might help treat hair loss from alopecia areata, but more research is needed to confirm safety and effectiveness.

Y27632 increases cell growth through EGFR signaling, not ROCK1/2.

Alopecia areata and atopic dermatitis share immune system issues, and treatments like JAK inhibitors can help both.

Stem cell therapies show promise for hair regrowth in alopecia areata but need more research for safety and effectiveness.

Natural killer and CD8+ T cells play a key role in hair loss in androgenetic alopecia.

Alopecia Areata causes hair loss and needs treatments that address both physical and emotional health.

Platelet-rich fibrin may help reduce nonmelanoma skin cancer cell growth.

No single ideal JAK inhibitor for alopecia areata has been determined; JAK3 inhibitors may be promising with fewer side effects.

Applying the anti-cancer drug Bortezomib to skin can promote hair growth and increase hair proteins through the GATA-3 factor.